Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Economic consequences of idiopathic pulmonary fibrosis in Denmark.

Hilberg O, Bendstrup E, Ibsen R, Løkke A, Hyldgaard C.

ERJ Open Res. 2018 May 25;4(2). pii: 00045-2017. doi: 10.1183/23120541.00045-2017. eCollection 2018 Apr.

2.

Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care.

Tupper OD, Kjeldgaard P, Løkke A, Ulrik CS.

Chron Respir Dis. 2018 Jan 1:1479972318761655. doi: 10.1177/1479972318761655. [Epub ahead of print]

PMID:
29486583
3.

The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.

Sikjær MG, Løkke A, Hilberg O.

Respir Med. 2018 Feb;135:35-41. doi: 10.1016/j.rmed.2017.12.012. Epub 2018 Jan 3.

PMID:
29414451
4.

Mindfulness-based cognitive therapy in COPD: a cluster randomised controlled trial.

Farver-Vestergaard I, O'Toole MS, O'Connor M, Løkke A, Bendstrup E, Basdeo SA, Cox DJ, Dunne PJ, Ruggeri K, Early F, Zachariae R.

Eur Respir J. 2018 Jan 31;51(2). pii: 1702082. doi: 10.1183/13993003.02082-2017. Print 2018 Feb.

PMID:
29386337
5.

Mrs Stone and Dr Smellie: British eighteenth-century birth attendance and long-run levels and trends in maternal mortality discussed in a north European context.

Løkke A.

Popul Stud (Camb). 2018 Mar;72(1):123-136. doi: 10.1080/00324728.2017.1415036. Epub 2018 Jan 23.

PMID:
29357758
6.

Co-morbidity and mortality among patients with interstitial lung diseases: A population-based study.

Hilberg O, Bendstrup E, Løkke A, Ibsen R, Fløe A, Hyldgaard C.

Respirology. 2018 Jun;23(6):606-612. doi: 10.1111/resp.13234. Epub 2017 Dec 18.

PMID:
29251396
7.

Comorbidities, mortality and causes of death among patients with tuberculosis in Denmark 1998-2010: a nationwide, register-based case-control study.

Fløe A, Hilberg O, Wejse C, Ibsen R, Løkke A.

Thorax. 2018 Jan;73(1):70-77. doi: 10.1136/thoraxjnl-2016-209240. Epub 2017 Aug 4.

PMID:
28778918
8.

Dietary beetroot juice - effects on physical performance in COPD patients: a randomized controlled crossover trial.

Friis AL, Steenholt CB, Løkke A, Hansen M.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 15;12:1765-1773. doi: 10.2147/COPD.S135752. eCollection 2017.

9.

Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review.

Bock K, Bendstrup E, Hilberg O, Løkke A.

Eur Clin Respir J. 2017 Jan 1;4(1):1332931. doi: 10.1080/20018525.2017.1332931. eCollection 2017.

10.

A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.

Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Løkke A, Bendstrup E, Ellingsen T.

Ann Rheum Dis. 2017 Oct;76(10):1700-1706. doi: 10.1136/annrheumdis-2017-211138. Epub 2017 Jun 13.

PMID:
28611082
11.

Preferred Place of Care and Death in Terminally Ill Patients with Lung and Heart Disease Compared to Cancer Patients.

Skorstengaard MH, Neergaard MA, Andreassen P, Brogaard T, Bendstrup E, Løkke A, Aagaard S, Wiggers H, Bech P, Jensen AB.

J Palliat Med. 2017 Nov;20(11):1217-1224. doi: 10.1089/jpm.2017.0082. Epub 2017 Jun 2.

PMID:
28574737
12.
13.

Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells.

Durfee PN, Lin YS, Dunphy DR, Muñiz AJ, Butler KS, Humphrey KR, Lokke AJ, Agola JO, Chou SS, Chen IM, Wharton W, Townson JL, Willman CL, Brinker CJ.

ACS Nano. 2016 Sep 27;10(9):8325-45. doi: 10.1021/acsnano.6b02819. Epub 2016 Jul 25.

PMID:
27419663
14.

Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia.

Søgaard M, Madsen M, Løkke A, Hilberg O, Sørensen HT, Thomsen RW.

Int J Chron Obstruct Pulmon Dis. 2016 Mar 2;11:455-65. doi: 10.2147/COPD.S96179. eCollection 2016.

15.

Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease.

Løkke A, Ahlbeck L, Bjermer L, Mortensen J, Østrem A, Pasternack I, Safioti G, Torvinen S.

Eur Clin Respir J. 2015 Dec 16;2:29445. doi: 10.3402/ecrj.v2.29445. eCollection 2015.

16.

Airway foreign body aspiration: common, yet easily overlooked! Two interesting cases.

Møller J, Rasmussen F, Hilberg O, Løkke A.

BMJ Case Rep. 2015 May 22;2015. pii: bcr2014209240. doi: 10.1136/bcr-2014-209240.

17.

The economic burden of tuberculosis in Denmark 1998-2010. Cost analysis in patients and their spouses.

Fløe A, Hilberg O, Wejse C, Løkke A, Ibsen R, Kjellberg J, Jennum P.

Int J Infect Dis. 2015 Mar;32:183-90. doi: 10.1016/j.ijid.2014.12.021.

18.

Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?

Kjeldgaard P, Dahl R, Løkke A, Ulrik CS.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 23;10:407-14. doi: 10.2147/COPD.S76047. eCollection 2015.

19.

[COPD and perception of the new GOLD document in Europe. Workshop from the Société de pneumologie de langue française (SPLF)].

Zysman M, Patout M, Miravitlles M, van der Molen T, Lokke A, Hausen T, Didier A, Cuvelier A, Roche N.

Rev Mal Respir. 2014 Jun;31(6):499-510. doi: 10.1016/j.rmr.2014.02.014. Epub 2014 May 9. Review. French.

PMID:
25012036
20.

Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998-2010.

Løkke A, Hilberg O, Tønnesen P, Ibsen R, Kjellberg J, Jennum P.

BMJ Open. 2014 Jan 6;4(1):e004069. doi: 10.1136/bmjopen-2013-004069.

21.

Economic and health consequences of COPD patients and their spouses in Denmark--1998-2010.

Løkke A, Hilberg O, Kjellberg J, Ibsen R, Jennum P.

COPD. 2014 Jun;11(3):237-46. doi: 10.3109/15412555.2013.839647. Epub 2013 Dec 19.

PMID:
24354969
22.

Severe interstitial lung disease following treatment with certolizumab pegol: a case report.

Lager J, Hilberg O, Løkke A, Bendstrup E.

Eur Respir Rev. 2013 Sep 1;22(129):414-6. doi: 10.1183/09059180.00002013. No abstract available.

23.

[New guidelines for diagnosis and staging of chronic obstructive pulmonary disease].

Løkke A, Dahl R.

Ugeskr Laeger. 2013 Apr 29;175(18):1257-60. Review. Danish.

PMID:
23651801
24.

Impact of diagnostic criteria on the prevalence of COPD.

Çolak Y, Løkke A, Marott JL, Lange P, Vestbo J.

Clin Respir J. 2013 Jul;7(3):297-303. doi: 10.1111/crj.12007. Epub 2012 Nov 22.

PMID:
23072716
25.

Detection of previously undiagnosed cases of COPD in a high-risk population identified in general practice.

Løkke A, Ulrik CS, Dahl R, Plauborg L, Dollerup J, Kristiansen LC, Cording PH, Dehlendorff C; TOP GOLD study-group.

COPD. 2012 Aug;9(5):458-65. doi: 10.3109/15412555.2012.685118. Epub 2012 May 29.

PMID:
22643016
26.

New Danish reference values for spirometry.

Løkke A, Marott JL, Mortensen J, Nordestgaard BG, Dahl M, Lange P.

Clin Respir J. 2013 Apr;7(2):153-67.

PMID:
22583805
27.

[Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].

Dahl R, Hilberg O, Løkke A, Pedersen L, Ringbæk T, Titlestad I.

Ugeskr Laeger. 2011 Oct 17;173(42):2645-7. Danish.

PMID:
22027165
28.

[Prevalence, symptoms, and diagnosis of tuberculosis in Denmark].

Hilberg O, Hyldgaard C, Løkke A.

Ugeskr Laeger. 2011 Mar 21;173(12):876-9. Danish.

PMID:
21419055
29.

Early detection of COPD in general practice.

Ulrik CS, Løkke A, Dahl R, Dollerup J, Hansen G, Cording PH, Andersen KK; TOP study group.

Int J Chron Obstruct Pulmon Dis. 2011;6:123-7. doi: 10.2147/COPD.S16929. Epub 2011 Jan 27.

30.

Prevalence of COPD in Copenhagen.

Fabricius P, Løkke A, Marott JL, Vestbo J, Lange P.

Respir Med. 2011 Mar;105(3):410-7. doi: 10.1016/j.rmed.2010.09.019. Epub 2010 Oct 16.

31.

[Walk-in spirometry pilot project for discovering of early chronic obstructive pulmonary disease].

Løkke A, Christensen LB, Fuglsang C.

Ugeskr Laeger. 2009 Oct 19;171(43):3083-8. Danish.

PMID:
19852895
32.

[Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study].

Løkke A, Fabricius PG, Vestbo J, Marott JL, Lange P.

Ugeskr Laeger. 2007 Nov 12;169(46):3956-60. Danish.

PMID:
18078648
33.
34.

[Developing COPD--25 years follow-up study of the general population].

Løkke A, Lange P, Vestbo J, Fabricius PG.

Ugeskr Laeger. 2006 Dec 11;168(50):4422-4. Danish.

PMID:
17217870
35.

Developing COPD: a 25 year follow up study of the general population.

Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J.

Thorax. 2006 Nov;61(11):935-9.

36.

Two hundred years of evidence-based perinatal care: late-fetal mortality in the past.

Woods RI, Løkke A, van Poppel F.

Arch Dis Child Fetal Neonatal Ed. 2006 Nov;91(6):F445-7. No abstract available.

37.

Exhaled CO, a predictor of lung function?

Fabricius P, Scharling H, Løkke A, Vestbo J, Lange P.

Respir Med. 2007 Mar;101(3):581-6. Epub 2006 Aug 8.

38.

Association of the 120-bp duplication in the dopamine D4 receptor gene and schizophrenia in a sample of Danish subjects.

Olsen L, Timm S, Wang AG, Søeby K, Jakobsen KD, Clemmensen S, Løkke A, Fossum M, Parnas J, Hemmingsen R, Rasmussen HB, Werge T.

Schizophr Res. 2005 Feb 1;73(1):133-5. No abstract available.

PMID:
15567086
39.

[Children's health. 11. Children and their parents: 300 years development history].

Jacobsen AF, Løkke A.

Sygeplejersken. 1987 Apr 15;87(16-17):12-8. Danish. No abstract available.

PMID:
3299844

Supplemental Content

Support Center